Social marketing: Should it be used to promote evidence-based health information?

被引:20
作者
Formoso, Giulio [1 ]
Marata, Anna Maria [1 ]
Magrini, Nicola [1 ]
机构
[1] CeVEAS Ctr Evaluat Effectiveness Hlth Care, Pharmacoepidemiol Unit, I-41100 Modena, Italy
关键词
independent drug information; knowledge translation; evidence-based medicines; social marketing; critical appraisal;
D O I
10.1016/j.socscimed.2006.09.022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The implementation of public health knowledge is a complex process; researchers focus on organizational barriers but generally give little attention to the format and validity of relevant information. Primary and secondary papers and practice guidelines should represent valid and relevant sources of knowledge for clinicians and others involved in public health. However, this information is usually targeted at researchers rather than practitioners; it is often not completely intelligible, does not explain what it really adds to existing knowledge or which clinical/organizational context to place it in, and often lacks 'appeal' for those who are less informed. Moreover, this information is sometimes founded on biased research, shaped by sponsors to give scientific plausibility to market-driven messages. A "social marketing" approach can help public health researchers make evidence-based information clear and appealing. The validity and relevance of this information can be explained to target readers in light of their own knowledge levels and in terms of how this information could help their practice. In this paper we analyse the barriers to knowledge transfer that are often inherent in the format of the information, and propose a more User-friendly, enriched and non-research-article format. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:949 / 953
页数:5
相关论文
共 20 条
[1]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[2]   Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles [J].
Chan, AW ;
Hróbjartsson, A ;
Haahr, MT ;
Gotzsche, PC ;
Altman, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20) :2457-2465
[3]   The pharmaceutical industry as an informant [J].
Collier, J ;
Iheanacho, I .
LANCET, 2002, 360 (9343) :1405-1409
[4]   The case for knowledge translation: shortening the journey from evidence to effect [J].
Davis, D ;
Evans, M ;
Jadad, A ;
Perrier, L ;
Rath, D ;
Ryan, D ;
Sibbald, G ;
Straus, S ;
Rappolt, S ;
Wowk, M ;
Zwarenstein, M .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7405) :33-35
[5]   THE EXISTENCE OF PUBLICATION BIAS AND RISK-FACTORS FOR ITS OCCURRENCE [J].
DICKERSIN, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (10) :1385-1389
[6]   Accountability of the pharmaceutical industry [J].
Dukes, MNG .
LANCET, 2002, 360 (9346) :1682-1684
[7]   Obstacles to answering doctors' questions about patient care with evidence: qualitative study [J].
Ely, JW ;
Osheroff, JA ;
Ebell, MH ;
Chambliss, ML ;
Vinson, DC ;
Stevermer, JJ ;
Pifer, EA .
BRITISH MEDICAL JOURNAL, 2002, 324 (7339) :710-713
[8]   Failures of the therapeutic chain as a cause of drug ineffectiveness - Promotion, misinformation, and economics work better than needs [J].
Figueras, A ;
Laporte, JR .
BRITISH MEDICAL JOURNAL, 2003, 326 (7395) :895-896
[9]   Practice guidelines:: Useful and "participative" method?: Survey of Italian physicians by professional setting [J].
Formoso, G ;
Liberati, A ;
Magrini, N .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (16) :2037-2042
[10]   Why general practitioners do not implement evidence: qualitative study [J].
Freeman, AC ;
Sweeney, K .
BRITISH MEDICAL JOURNAL, 2001, 323 (7321) :1100-1102A